NATCO Pharma Limited announces the launch of additional strengths for the generic version of Revlimid (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, via an exchange filing.
The launch is through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.
With this launch the companies made available all the strengths of lenalidomide in the US market.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Watch: Pakistan U19 Players Celebrate Asia Cup 2025 Win With Viral 'FA9LA' Dance
Donald Trump's Photo In Epstein Files Restored Following Criticism, US Department Of Justice Explains Why It Was Removed
Who Was Srinivasa Ramanujan? Everything You Need To Know About The Man Who Knew Infinity
Kyunki Saas Bhi Kabhi Bahu Thi 2 Written Update, December 21: Pari Faces Ranvijay's Abuse
